You're right. I unknowingly conflated 401 and 501.
From our website -
"We are also developing a follow-on compound utilizing our proprietary ddRNAi proprietary technology to silence EGFR. Named, BB-501, early stage iterations of this candidate are currently being tested in preclinical animal testing using xenograft tumour models."
Add to My Watchlist
What is My Watchlist?
